Viewing Study NCT06322927



Ignite Creation Date: 2024-05-06 @ 8:17 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06322927
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-21
First Post: 2024-03-14

Brief Title: PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
Sponsor: The Christie NHS Foundation Trust
Organization: The Christie NHS Foundation Trust

Study Overview

Official Title: PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: iPREFER
Brief Summary: This is a qualitative interview study to explore the experiences of people receiving treatment for MM and to understand what matters most to them when making treatment decisions
Detailed Description: People can receive many lines of treatment for multiple myeloma We would like to understand more about the experiences of people being treated for multiple myeloma including what matters most to them when considering treatment options how their experiences have differed with different treatments and if they have any treatment preferences Patients at The Christie who have received five or more lines of treatment for Multiple Myeloma will be eligible to take part in this study They will be asked to participate in an interview which should take approximately 30 minutes to an hour During the interview they will be asked questions regarding their experiences and preference for treatment Interviews will be conducted either in person or over the phone depending on patient preference The interviews will be recorded by the research team using a Dictaphone and transcribed by an external transcription service called 1st Class Secretarial The transcripts of all participant interviews will be reviewed by members of the research team and experiences will be identified and described

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
24_CPCR_38 OTHER ChristieNHS None